nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C9—Capecitabine—esophageal cancer	0.0147	0.665	CbGbCtD
Moclobemide—CYP2C9—Cisplatin—esophageal cancer	0.00741	0.335	CbGbCtD
Moclobemide—Proctalgia—Capecitabine—esophageal cancer	0.00673	0.0325	CcSEcCtD
Moclobemide—Appetite absent—Methotrexate—esophageal cancer	0.00472	0.0228	CcSEcCtD
Moclobemide—Dysarthria—Cisplatin—esophageal cancer	0.00453	0.0218	CcSEcCtD
Moclobemide—Metrorrhagia—Capecitabine—esophageal cancer	0.00442	0.0213	CcSEcCtD
Moclobemide—Extrasystoles—Capecitabine—esophageal cancer	0.00375	0.0181	CcSEcCtD
Moclobemide—Polyuria—Cisplatin—esophageal cancer	0.00354	0.0171	CcSEcCtD
Moclobemide—Dysarthria—Capecitabine—esophageal cancer	0.00334	0.0161	CcSEcCtD
Moclobemide—Gingivitis—Methotrexate—esophageal cancer	0.00299	0.0144	CcSEcCtD
Moclobemide—Irritability—Cisplatin—esophageal cancer	0.00297	0.0143	CcSEcCtD
Moclobemide—Urine output increased—Capecitabine—esophageal cancer	0.00285	0.0138	CcSEcCtD
Moclobemide—Sleep disorder—Capecitabine—esophageal cancer	0.00265	0.0128	CcSEcCtD
Moclobemide—Polyuria—Capecitabine—esophageal cancer	0.00261	0.0126	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00249	0.012	CcSEcCtD
Moclobemide—Dysarthria—Methotrexate—esophageal cancer	0.00249	0.012	CcSEcCtD
Moclobemide—Hot flush—Capecitabine—esophageal cancer	0.00245	0.0118	CcSEcCtD
Moclobemide—Menopausal symptoms—Capecitabine—esophageal cancer	0.00243	0.0117	CcSEcCtD
Moclobemide—Stomatitis—Cisplatin—esophageal cancer	0.00234	0.0113	CcSEcCtD
Moclobemide—Conjunctivitis—Cisplatin—esophageal cancer	0.00233	0.0112	CcSEcCtD
Moclobemide—Osteoarthritis—Capecitabine—esophageal cancer	0.00229	0.0111	CcSEcCtD
Moclobemide—Migraine—Capecitabine—esophageal cancer	0.00226	0.0109	CcSEcCtD
Moclobemide—Bradycardia—Cisplatin—esophageal cancer	0.00219	0.0106	CcSEcCtD
Moclobemide—Irritability—Capecitabine—esophageal cancer	0.00219	0.0105	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—esophageal cancer	0.00213	0.0102	CcSEcCtD
Moclobemide—Dry skin—Capecitabine—esophageal cancer	0.0021	0.0101	CcSEcCtD
Moclobemide—Visual impairment—Cisplatin—esophageal cancer	0.00207	0.01	CcSEcCtD
Moclobemide—Gastritis—Capecitabine—esophageal cancer	0.00203	0.00978	CcSEcCtD
Moclobemide—Tinnitus—Cisplatin—esophageal cancer	0.00201	0.00967	CcSEcCtD
Moclobemide—Flushing—Cisplatin—esophageal cancer	0.002	0.00963	CcSEcCtD
Moclobemide—Abdominal distension—Capecitabine—esophageal cancer	0.00199	0.00962	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—esophageal cancer	0.00194	0.00937	CcSEcCtD
Moclobemide—Angina pectoris—Capecitabine—esophageal cancer	0.00193	0.00931	CcSEcCtD
Moclobemide—Dysuria—Capecitabine—esophageal cancer	0.00185	0.00893	CcSEcCtD
Moclobemide—Flatulence—Cisplatin—esophageal cancer	0.00185	0.0089	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—esophageal cancer	0.0018	0.00868	CcSEcCtD
Moclobemide—Vision blurred—Cisplatin—esophageal cancer	0.00176	0.00851	CcSEcCtD
Moclobemide—Tremor—Cisplatin—esophageal cancer	0.00175	0.00846	CcSEcCtD
Moclobemide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00174	0.00838	CcSEcCtD
Moclobemide—Stomatitis—Capecitabine—esophageal cancer	0.00172	0.0083	CcSEcCtD
Moclobemide—Conjunctivitis—Capecitabine—esophageal cancer	0.00172	0.00828	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—esophageal cancer	0.00171	0.00823	CcSEcCtD
Moclobemide—Malaise—Cisplatin—esophageal cancer	0.00169	0.00814	CcSEcCtD
Moclobemide—Irritability—Methotrexate—esophageal cancer	0.00163	0.00785	CcSEcCtD
Moclobemide—Bradycardia—Capecitabine—esophageal cancer	0.00161	0.00778	CcSEcCtD
Moclobemide—Myalgia—Cisplatin—esophageal cancer	0.00159	0.00769	CcSEcCtD
Moclobemide—Anxiety—Cisplatin—esophageal cancer	0.00159	0.00766	CcSEcCtD
Moclobemide—Discomfort—Cisplatin—esophageal cancer	0.00158	0.0076	CcSEcCtD
Moclobemide—Visual impairment—Capecitabine—esophageal cancer	0.00153	0.00737	CcSEcCtD
Moclobemide—Tachycardia—Cisplatin—esophageal cancer	0.00149	0.00719	CcSEcCtD
Moclobemide—Tinnitus—Capecitabine—esophageal cancer	0.00148	0.00713	CcSEcCtD
Moclobemide—Hyperhidrosis—Cisplatin—esophageal cancer	0.00148	0.00712	CcSEcCtD
Moclobemide—Flushing—Capecitabine—esophageal cancer	0.00147	0.0071	CcSEcCtD
Moclobemide—Hypotension—Cisplatin—esophageal cancer	0.00143	0.00689	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00139	0.00671	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—esophageal cancer	0.00138	0.00665	CcSEcCtD
Moclobemide—Paraesthesia—Cisplatin—esophageal cancer	0.00137	0.00662	CcSEcCtD
Moclobemide—Dyspnoea—Cisplatin—esophageal cancer	0.00136	0.00657	CcSEcCtD
Moclobemide—Flatulence—Capecitabine—esophageal cancer	0.00136	0.00656	CcSEcCtD
Moclobemide—Dysgeusia—Capecitabine—esophageal cancer	0.00135	0.00652	CcSEcCtD
Moclobemide—Decreased appetite—Cisplatin—esophageal cancer	0.00133	0.00641	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—esophageal cancer	0.00131	0.00634	CcSEcCtD
Moclobemide—Vision blurred—Capecitabine—esophageal cancer	0.0013	0.00627	CcSEcCtD
Moclobemide—Tremor—Capecitabine—esophageal cancer	0.00129	0.00624	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—esophageal cancer	0.00128	0.00618	CcSEcCtD
Moclobemide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00128	0.00618	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—esophageal cancer	0.00128	0.00616	CcSEcCtD
Moclobemide—Sweating—Methotrexate—esophageal cancer	0.00126	0.00608	CcSEcCtD
Moclobemide—Feeling abnormal—Cisplatin—esophageal cancer	0.00126	0.00607	CcSEcCtD
Moclobemide—Malaise—Capecitabine—esophageal cancer	0.00124	0.006	CcSEcCtD
Moclobemide—Syncope—Capecitabine—esophageal cancer	0.00124	0.00597	CcSEcCtD
Moclobemide—Palpitations—Capecitabine—esophageal cancer	0.00122	0.00588	CcSEcCtD
Moclobemide—Loss of consciousness—Capecitabine—esophageal cancer	0.00121	0.00585	CcSEcCtD
Moclobemide—Hypertension—Capecitabine—esophageal cancer	0.00119	0.00575	CcSEcCtD
Moclobemide—Chest pain—Capecitabine—esophageal cancer	0.00118	0.00567	CcSEcCtD
Moclobemide—Myalgia—Capecitabine—esophageal cancer	0.00118	0.00567	CcSEcCtD
Moclobemide—Anxiety—Capecitabine—esophageal cancer	0.00117	0.00565	CcSEcCtD
Moclobemide—Discomfort—Capecitabine—esophageal cancer	0.00116	0.0056	CcSEcCtD
Moclobemide—Dry mouth—Capecitabine—esophageal cancer	0.00115	0.00554	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—esophageal cancer	0.00114	0.00549	CcSEcCtD
Moclobemide—Confusional state—Capecitabine—esophageal cancer	0.00114	0.00548	CcSEcCtD
Moclobemide—Shock—Capecitabine—esophageal cancer	0.00111	0.00534	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—esophageal cancer	0.0011	0.00531	CcSEcCtD
Moclobemide—Tachycardia—Capecitabine—esophageal cancer	0.0011	0.0053	CcSEcCtD
Moclobemide—Asthenia—Cisplatin—esophageal cancer	0.0011	0.00529	CcSEcCtD
Moclobemide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00109	0.00525	CcSEcCtD
Moclobemide—Hypotension—Capecitabine—esophageal cancer	0.00105	0.00508	CcSEcCtD
Moclobemide—Diarrhoea—Cisplatin—esophageal cancer	0.00105	0.00504	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00103	0.00495	CcSEcCtD
Moclobemide—Insomnia—Capecitabine—esophageal cancer	0.00102	0.00491	CcSEcCtD
Moclobemide—Paraesthesia—Capecitabine—esophageal cancer	0.00101	0.00488	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—esophageal cancer	0.00101	0.00485	CcSEcCtD
Moclobemide—Dyspnoea—Capecitabine—esophageal cancer	0.001	0.00484	CcSEcCtD
Moclobemide—Dyspepsia—Capecitabine—esophageal cancer	0.000992	0.00478	CcSEcCtD
Moclobemide—Decreased appetite—Capecitabine—esophageal cancer	0.000979	0.00472	CcSEcCtD
Moclobemide—Vomiting—Cisplatin—esophageal cancer	0.000972	0.00469	CcSEcCtD
Moclobemide—Fatigue—Capecitabine—esophageal cancer	0.000971	0.00468	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—esophageal cancer	0.000968	0.00467	CcSEcCtD
Moclobemide—Rash—Cisplatin—esophageal cancer	0.000964	0.00465	CcSEcCtD
Moclobemide—Constipation—Capecitabine—esophageal cancer	0.000963	0.00465	CcSEcCtD
Moclobemide—Dermatitis—Cisplatin—esophageal cancer	0.000963	0.00464	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000953	0.0046	CcSEcCtD
Moclobemide—Feeling abnormal—Capecitabine—esophageal cancer	0.000928	0.00448	CcSEcCtD
Moclobemide—Malaise—Methotrexate—esophageal cancer	0.000927	0.00447	CcSEcCtD
Moclobemide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000921	0.00444	CcSEcCtD
Moclobemide—Nausea—Cisplatin—esophageal cancer	0.000908	0.00438	CcSEcCtD
Moclobemide—Urticaria—Capecitabine—esophageal cancer	0.000895	0.00432	CcSEcCtD
Moclobemide—Abdominal pain—Capecitabine—esophageal cancer	0.000891	0.00429	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—esophageal cancer	0.000875	0.00422	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—esophageal cancer	0.000875	0.00422	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—esophageal cancer	0.000864	0.00417	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—esophageal cancer	0.000846	0.00408	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000811	0.00391	CcSEcCtD
Moclobemide—Asthenia—Capecitabine—esophageal cancer	0.000808	0.0039	CcSEcCtD
Moclobemide—Pruritus—Capecitabine—esophageal cancer	0.000797	0.00384	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—esophageal cancer	0.000784	0.00378	CcSEcCtD
Moclobemide—Diarrhoea—Capecitabine—esophageal cancer	0.000771	0.00372	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000764	0.00368	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—esophageal cancer	0.000758	0.00366	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—esophageal cancer	0.000753	0.00363	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—esophageal cancer	0.000748	0.00361	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—esophageal cancer	0.000746	0.0036	CcSEcCtD
Moclobemide—Dizziness—Capecitabine—esophageal cancer	0.000745	0.00359	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—esophageal cancer	0.000738	0.00356	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—esophageal cancer	0.000729	0.00352	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—esophageal cancer	0.000723	0.00349	CcSEcCtD
Moclobemide—Vomiting—Capecitabine—esophageal cancer	0.000716	0.00345	CcSEcCtD
Moclobemide—Rash—Capecitabine—esophageal cancer	0.00071	0.00343	CcSEcCtD
Moclobemide—Dermatitis—Capecitabine—esophageal cancer	0.00071	0.00342	CcSEcCtD
Moclobemide—Headache—Capecitabine—esophageal cancer	0.000706	0.0034	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—esophageal cancer	0.000691	0.00333	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000686	0.00331	CcSEcCtD
Moclobemide—Nausea—Capecitabine—esophageal cancer	0.000669	0.00323	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—esophageal cancer	0.000666	0.00321	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—esophageal cancer	0.000663	0.0032	CcSEcCtD
Moclobemide—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000646	0.000838	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC52A3—esophageal cancer	0.000642	0.000834	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BLVRB—esophageal cancer	0.000642	0.000834	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TYMP—esophageal cancer	0.00062	0.000805	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000619	0.000803	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000607	0.000788	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP26A1—esophageal cancer	0.000603	0.000783	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000602	0.000781	CbGpPWpGaD
Moclobemide—Asthenia—Methotrexate—esophageal cancer	0.000602	0.0029	CcSEcCtD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000594	0.000771	CbGpPWpGaD
Moclobemide—Pruritus—Methotrexate—esophageal cancer	0.000593	0.00286	CcSEcCtD
Moclobemide—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000589	0.000764	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALOX15—esophageal cancer	0.000588	0.000763	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000582	0.000755	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000581	0.000754	CbGpPWpGaD
Moclobemide—Diarrhoea—Methotrexate—esophageal cancer	0.000574	0.00277	CcSEcCtD
Moclobemide—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000568	0.000737	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000566	0.000735	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TPI1—esophageal cancer	0.000561	0.000728	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTO1—esophageal cancer	0.000561	0.000728	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000558	0.000724	CbGpPWpGaD
Moclobemide—Dizziness—Methotrexate—esophageal cancer	0.000555	0.00267	CcSEcCtD
Moclobemide—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000554	0.000719	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000552	0.000716	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000549	0.000712	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC10A2—esophageal cancer	0.000546	0.000709	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA1—esophageal cancer	0.000546	0.000709	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000546	0.000709	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000541	0.000703	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALDOB—esophageal cancer	0.000538	0.000698	CbGpPWpGaD
Moclobemide—Vomiting—Methotrexate—esophageal cancer	0.000533	0.00257	CcSEcCtD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000531	0.000689	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000529	0.000687	CbGpPWpGaD
Moclobemide—Rash—Methotrexate—esophageal cancer	0.000529	0.00255	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—esophageal cancer	0.000528	0.00255	CcSEcCtD
Moclobemide—Headache—Methotrexate—esophageal cancer	0.000525	0.00253	CcSEcCtD
Moclobemide—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000521	0.000676	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GAPDH—esophageal cancer	0.000518	0.000672	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000516	0.00067	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000515	0.000669	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000513	0.000666	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CRABP1—esophageal cancer	0.000513	0.000666	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000509	0.000661	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000505	0.000655	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000505	0.000655	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA2—esophageal cancer	0.0005	0.000648	CbGpPWpGaD
Moclobemide—Nausea—Methotrexate—esophageal cancer	0.000498	0.0024	CcSEcCtD
Moclobemide—MAOB—Metabolism—GNG7—esophageal cancer	0.000488	0.000633	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000469	0.000609	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PLCE1—esophageal cancer	0.000465	0.000603	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ADH7—esophageal cancer	0.000465	0.000603	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000463	0.0006	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALDH2—esophageal cancer	0.000457	0.000594	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000452	0.000587	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000441	0.000572	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00044	0.000571	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTT1—esophageal cancer	0.000435	0.000565	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000435	0.000564	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00043	0.000559	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00043	0.000559	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP2A6—esophageal cancer	0.00043	0.000558	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ENO1—esophageal cancer	0.000408	0.000529	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS1—esophageal cancer	0.000408	0.000529	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ADH1B—esophageal cancer	0.000407	0.000529	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSME2—esophageal cancer	0.000402	0.000521	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSME1—esophageal cancer	0.000402	0.000521	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000392	0.000509	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TYMP—esophageal cancer	0.000389	0.000505	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP26A1—esophageal cancer	0.000379	0.000491	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALOX15—esophageal cancer	0.000369	0.000479	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000358	0.000464	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TPI1—esophageal cancer	0.000352	0.000457	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTO1—esophageal cancer	0.000352	0.000457	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1B1—esophageal cancer	0.000347	0.00045	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000342	0.000444	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALDOB—esophageal cancer	0.000338	0.000438	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP19A1—esophageal cancer	0.000326	0.000423	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GAPDH—esophageal cancer	0.000325	0.000422	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CRABP1—esophageal cancer	0.000322	0.000418	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000312	0.000405	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GNG7—esophageal cancer	0.000306	0.000397	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000306	0.000397	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000304	0.000395	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000304	0.000395	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—HMOX1—esophageal cancer	0.000297	0.000386	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALDH2—esophageal cancer	0.000287	0.000372	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCB1—esophageal cancer	0.000285	0.00037	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.00028	0.000363	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.00028	0.000363	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000277	0.00036	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000277	0.00036	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTT1—esophageal cancer	0.000273	0.000354	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000272	0.000353	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2A6—esophageal cancer	0.00027	0.00035	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000267	0.000346	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000259	0.000336	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA1—esophageal cancer	0.000259	0.000336	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS1—esophageal cancer	0.000256	0.000332	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ENO1—esophageal cancer	0.000256	0.000332	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSME2—esophageal cancer	0.000252	0.000327	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSME1—esophageal cancer	0.000252	0.000327	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000248	0.000322	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA1—esophageal cancer	0.000238	0.000309	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000238	0.000309	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000237	0.000308	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000237	0.000308	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA2—esophageal cancer	0.000237	0.000307	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000236	0.000306	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA1—esophageal cancer	0.000236	0.000306	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000231	0.0003	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.00022	0.000285	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADH7—esophageal cancer	0.00022	0.000285	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA2—esophageal cancer	0.000218	0.000282	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1B1—esophageal cancer	0.000217	0.000282	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000217	0.000282	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA2—esophageal cancer	0.000216	0.00028	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000212	0.000275	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000211	0.000274	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP19A1—esophageal cancer	0.000204	0.000265	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000202	0.000262	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000202	0.000262	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA1—esophageal cancer	0.000201	0.000261	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000201	0.000261	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.0002	0.00026	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADH7—esophageal cancer	0.0002	0.00026	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000198	0.000257	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000193	0.00025	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CREBBP—esophageal cancer	0.000191	0.000248	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMOX1—esophageal cancer	0.000187	0.000242	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA2—esophageal cancer	0.000184	0.000239	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000184	0.000239	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00018	0.000234	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000179	0.000233	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCB1—esophageal cancer	0.000179	0.000232	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000177	0.00023	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000176	0.000228	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000175	0.000227	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000171	0.000222	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000171	0.000222	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NOS3—esophageal cancer	0.000171	0.000222	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000169	0.00022	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000169	0.00022	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000168	0.000218	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.000167	0.000216	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TPI1—esophageal cancer	0.000167	0.000216	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000165	0.000214	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000163	0.000212	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000161	0.000209	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.00016	0.000207	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000159	0.000207	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—esophageal cancer	0.000156	0.000203	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000154	0.0002	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000153	0.000199	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000153	0.000199	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.000152	0.000198	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.000152	0.000197	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TPI1—esophageal cancer	0.000152	0.000197	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.00015	0.000195	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000147	0.000191	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000146	0.000189	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNG7—esophageal cancer	0.000145	0.000188	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000144	0.000186	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000141	0.000184	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.00014	0.000182	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.00014	0.000182	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.00014	0.000181	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000139	0.00018	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000136	0.000177	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDH2—esophageal cancer	0.000136	0.000176	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000133	0.000173	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000132	0.000172	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—EP300—esophageal cancer	0.00013	0.000169	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TPI1—esophageal cancer	0.00013	0.000169	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.00013	0.000169	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—esophageal cancer	0.000129	0.000168	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2A6—esophageal cancer	0.000128	0.000166	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000127	0.000165	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000125	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000124	0.000162	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000124	0.000161	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS1—esophageal cancer	0.000121	0.000157	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO1—esophageal cancer	0.000121	0.000157	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.00012	0.000156	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CREBBP—esophageal cancer	0.00012	0.000155	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSME2—esophageal cancer	0.000119	0.000155	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSME1—esophageal cancer	0.000119	0.000155	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000119	0.000154	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000119	0.000154	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000118	0.000153	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000117	0.000152	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000116	0.000151	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000116	0.000151	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000113	0.000147	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000111	0.000145	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000111	0.000145	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.00011	0.000143	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO1—esophageal cancer	0.00011	0.000143	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSME1—esophageal cancer	0.00011	0.000142	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSME2—esophageal cancer	0.00011	0.000142	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000109	0.000141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000109	0.000141	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—esophageal cancer	0.000107	0.000139	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.000106	0.000137	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000104	0.000135	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1B1—esophageal cancer	0.000103	0.000134	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.000101	0.000131	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.95e-05	0.000129	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.91e-05	0.000129	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—esophageal cancer	9.8e-05	0.000127	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP19A1—esophageal cancer	9.68e-05	0.000126	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—esophageal cancer	9.61e-05	0.000125	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.5e-05	0.000123	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1B1—esophageal cancer	9.47e-05	0.000123	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO1—esophageal cancer	9.43e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS1—esophageal cancer	9.43e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	9.39e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSME1—esophageal cancer	9.3e-05	0.000121	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSME2—esophageal cancer	9.3e-05	0.000121	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP19A1—esophageal cancer	8.9e-05	0.000116	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—esophageal cancer	8.83e-05	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.83e-05	0.000115	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.66e-05	0.000112	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—esophageal cancer	8.48e-05	0.00011	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—EP300—esophageal cancer	8.15e-05	0.000106	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.12e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.12e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.05e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1B1—esophageal cancer	8.02e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.9e-05	0.000103	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—esophageal cancer	7.8e-05	0.000101	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.73e-05	0.0001	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.54e-05	9.79e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.88e-05	8.93e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.75e-05	8.76e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.61e-05	8.57e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.41e-05	8.32e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—esophageal cancer	6.03e-05	7.83e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.84e-05	7.58e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.67e-05	7.35e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.21e-05	6.76e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.17e-05	6.7e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—esophageal cancer	5.07e-05	6.58e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.99e-05	6.48e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—esophageal cancer	4.67e-05	6.06e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.64e-05	6.02e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—esophageal cancer	4.63e-05	6e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.41e-05	5.73e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.27e-05	5.54e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.23e-05	5.49e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—esophageal cancer	3.95e-05	5.13e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—EP300—esophageal cancer	3.86e-05	5.01e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.62e-05	4.69e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—EP300—esophageal cancer	3.55e-05	4.61e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—EP300—esophageal cancer	3.52e-05	4.57e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EP300—esophageal cancer	3.01e-05	3.9e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.85e-05	3.7e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.63e-05	3.41e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.6e-05	3.38e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.22e-05	2.89e-05	CbGpPWpGaD
